Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Tarancon-Diez, L; Lazaro-Martin, B; Goicoechea-Martínez, J; Domínguez-Romero, R; Sirvent, JG; Garrote, E; Domingo, LM; Cervantes-Hernández, E; Gavilán, C; Fortuny, C; Bernardino, JI; Diez, C; Montero-Alonso, M; Roca-Oporto, C; Ocampo, A; Jiménez, AB; Rius, N; Segura, NL; Escosa-García, L; Prieto, L; Ramos, JT; Navarro-Gomez, ML.

Clinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2026; 81(4): [doi:10.1093/jac/dkag079]

Navarro-Soler, R; Muriel, A; Fanciulli, C; Bernardino, JI; Sáez, C; Fernandez-Felix, BM; de Morales, AGG; Zamora, J; de Cea, AM; Martínez-Sanz, J; Moreno, S; Serrano-Villar, S.

Towards tuberculosis elimination in people with HIV on antiretroviral therapy: evidence from a two-decade nationwide cohort in Spain

Infectious Diseases of Poverty. 2026; 15(1): [doi:10.1186/s40249-026-01426-9]

Grande-Garcia, S; Llamas-Adán, M; Crespo-Bermejo, C; Lara-Aguilar, V; Arca-Lafuente, S; Martin-Carbonero, L; Ryan, P; de los Santos, I; de Lagarde, M; Mican-Rivera, R; Moreno, S; Resino, S; Berenguer, J; Briz, V; Fernández-Rodriguez, A; CoRIS Cohort.

Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance

Journal of Infection and Public Health. 2026; 19(3): 103108-103108 Nº de citas: 1 [doi:10.1016/j.jiph.2025.103108]

Ryan, P; Berenguer, J.

Hepatitis C elimination in people with HIV: progress, gaps, and future directions

Current Opinion in HIV and AIDS. 2026; 21(2): 160-165 [doi:10.1097/COH.0000000000000999]

Perez-Latorre, L; Cohen, SH; Sánchez, PJ; De Antonio, R; Mertz, S; Ye, F; Pifer, T; Rodriguez-Molino, P; Kim, H; Eisner, M; Rijal, M; Xu, ZH; Rood, K; Abdelwahab, M; Reyes, O; Peeples, ME; Thongpan, I; Bartholomew, A; Saez-Llorens, X; Costantine, MM; Mejias, A; Ramilo, O.

SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer

PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2026; 45(3): 271-279 [doi:10.1097/INF.0000000000005032]

Moreno-Lopez, R; Lazaro-Martin, B; Díez, C; Navarro-Gomez, ML; Tarancon-Diez, L.

Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants

Frontiers in Endocrinology. 2026; 17: [doi:10.3389/fendo.2026.1734023]

Martín-Escolano, R; Fernández-Rodríguez, A; Tarancon-Diez, L; Berenguer, J; Codina, H; Amigot-Sánchez, R; González-García, J; Hontañón, V; Pérez-Latorre, L; Ibañez-Samaniego, L; Llop-Herrera, E; Olveira, A; Díaz, L; Martínez, I; Jiménez-Sousa, MA; Resino, S.

HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis

Frontiers in Immunology. 2026; 17: [doi:10.3389/fimmu.2026.1683092]

Troya, J; Mican, R; Galindo, MJ; Bisbal, O; Romero, L; Torralba, M; Buzón-Martín, L; de la Fuente, S; Fanjul, F; Rodríguez, A; Cabello, A; Sanjoaquin, I; Navarro, MD; Aguilera, M; Hidalgo-Tenorio, C; Morano, LE; Martínez, C; Poquet, I; Bernal, E; Caballero, R; Cabello-Clotet, N; Fernández, A; Montero, MD; Vivancos-Gallego, MJ; Tejerina, F; Soria, G; de Zárraga, MA; Cairó, M; Romero, A; Cabo, R; Arenas, V; Sepúlveda, MA; Alcaraz, A; Escrich, C; González-Rico, C; Ferreira, EM; Valentín, B; Muelas-Fernández, M; Llenas-García, J; García, S; Losa-García, JE; Alonso, B; Sanz, J; Gutiérrez, F; Vázquez, N; Corte, JJ; Garcinuño, MA; Gainzarain, JC; Estébanez, M; Pedrero-Tomé, R; Montes, ML.

Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

HIV MEDICINE. 2026; : [doi:10.1111/hiv.70196]

Virseda-Berdices, A; Behar-Lagares, R; Berenguer, J; González-García, J; Requena, B; Brochado-Kith, O; Díez, C; Hontañon, V; Grande-García, S; González-Riano, C; Barbas, C; Resino, S; Fernández-Rodríguez, A; Jiménez-Sousa, MA.

Plasma miRNA-Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure

Pharmaceuticals. 2026; 19(1): [doi:10.3390/ph19010170]

Virseda-Berdices, A; Requena, B; Berenguer, J; González-García, J; Gonzalez-Riano, C; Díez, C; Hontañon, V; Fernández-Rodríguez, A; Barbas, C; Resino, S; Martín-Escolano, R; Jiménez-Sousa, MA.

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study

Frontiers in Immunology. 2026; 16: 1674837-1674837 [doi:10.3389/fimmu.2025.1674837]

Suárez-García, I; Alejos, B; Moreno, C; De Miguel, R; Aldámiz-Echevarría, T; García-Fraile, LJ; Pitarch, MT; Martinez, DP; Antela, A; Moreno, S; Jarrín, I.

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort

HIV MEDICINE. 2025; : [doi:10.1111/hiv.70183]

Van Santen, DK; Chalouni, M; Berenguer, J; Jarrin, I; Miro, JM; Klein, MB; Young, J; Torgersen, J; Rentsch, CT; Gill, MJ; Epstein, RL; Nunes, D; Surial, B; Rauch, A; Touloumi, G; Papadopoulos, A; Wittkop, L; Gilbert, C; Leleux, O; van der Valk, M; Boyd, A; Monforte, AD; Puoti, M; Zangerle, R; Gisinger, M; Logan, RW; Rein, S; Hernán, MA; Lodi, S.

Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With Human Immunodeficiency Virus

CLINICAL INFECTIOUS DISEASES. 2025; : [doi:10.1093/cid/ciaf635]

Martín-Quirós, A; Soriano, A; Tejerina-Picado, F; Güerri-Fernández, R; Cotarelo, M; Molloy, B; Fernández-Vigo, E; Chacón, F.

Baseline medication profile and risk of CYP3A4 mediated drug-drug interactions among COVID-19 hospitalized patients in Spain

BMC INFECTIOUS DISEASES. 2025; 26(1): [doi:10.1186/s12879-025-12240-3]

Ryan, P; Berenguer, J; Ramos-Ruperto, L; Vera, M; Martín-Carbonero, L; Pérez-Latorre, L; de los Santos, I; Pinto, A; Vivancos, MJ; Orviz, E; Alvarez, B; Sanz, J; Ruiz-Seco, P; Torres, R; Brazal, B; De Miguel, M; Lopez-Centeno, B; Jarrín, I; Resino, S; Bellon, JM; González-García, J.

Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)

Open Forum Infectious Diseases. 2025; 12(12): [doi:10.1093/ofid/ofaf678]

Vazquez-Alejo, E; Espinar-Buitrago, MD; Magro-Lopez, E; Tarancon-Diez, L; Díez, C; Bernardino, JI; Rull, A; de los Santos, I; Alonso, R; Zamora, A; Jiménez, JL; Muñoz-Fernández, MA.

Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study

MEDICAL MICROBIOLOGY AND IMMUNOLOGY. 2025; 214(1): [doi:10.1007/s00430-024-00813-z]

Virseda-Berdices, A; Requena, B; Berenguer, J; Gónzalez-Garcia, J; Gonzalez-Riano, C; Diez, C; Hontañón, V; Muñoz-Garcia, P; Fernández-Rodriguez, A; Barbas, C; Resino, S; Martin-Escolano, R; Jimenez-Sousa, MA.

Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis

Journal of Infection and Public Health. 2025; 18(12): [doi:10.1016/j.jiph.2025.102981]

Díez C; Pita-Martínez C; Quero-Delgado M; Gómez-Tórtola A; Fanciulli C; Marchan A; Aldámiz-Echevarría T; Sepúlveda-Crespo D; Tejerina F; Pérez-Latorre L; Gutiérrez I; López JC; Martínez I; Resino S.

Sex and age-related differences in humoral and cellular responses to the recombinant zoster vaccine in people living with HIV.

BIOMEDICINE & PHARMACOTHERAPY. 2025; 192: 118663-118663 [doi:10.1016/j.biopha.2025.118663]

Martínez-Martín, P; Esteban-Cantos, A; Jurado, F; Montejano, R; Gutiérrez-García, L; Grela, AD; González, JC; Marcelo, C; Vidal, AD; Arcos-Rueda, MD; Buckley, RD; Bernardino, J; Jiménez-González, M; de Lagarde, M; Sanz-Moreno, J; Ryan, P; Pérez, VE; Pérez-Latorre, L; Losa-García, JE; Rodés, B; Arribas, JR.

Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled Human Immunodeficiency Virus (HIV-1) Infection

CLINICAL INFECTIOUS DISEASES. 2025; : [doi:10.1093/cid/ciaf537]